June 18, 2022 Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease
June 4, 2022 Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease
May 17, 2022 Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T cell treatment
May 15, 2022 Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia
May 14, 2022 Diagnostic and prognostic performance to detect Alzheimer’s disease and clinical progression of a novel assay for plasma p-tau217
April 23, 2022 Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
April 19, 2022 Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders
April 5, 2022 Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer’s continuum
April 4, 2022 Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis